# Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

> **NCT02388659** · — · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 142 (actual)

## Conditions studied

- Malignant Gliomas
- Oligodendrogliomas
- Astrocytomas

## Interventions

- **DEVICE:** 3 Tesla scanning

## Key facts

- **NCT ID:** NCT02388659
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2023-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02388659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02388659, "Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02388659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*